Moshnenko, N.; Kazantsev, A.; Chupakhin, E.; Bakulina, O.; Dar’in, D. Synthetic Routes to Approved Drugs Containing a Spirocycle. Molecules2023, 28, 4209.
Moshnenko, N.; Kazantsev, A.; Chupakhin, E.; Bakulina, O.; Dar’in, D. Synthetic Routes to Approved Drugs Containing a Spirocycle. Molecules 2023, 28, 4209.
Moshnenko, N.; Kazantsev, A.; Chupakhin, E.; Bakulina, O.; Dar’in, D. Synthetic Routes to Approved Drugs Containing a Spirocycle. Molecules2023, 28, 4209.
Moshnenko, N.; Kazantsev, A.; Chupakhin, E.; Bakulina, O.; Dar’in, D. Synthetic Routes to Approved Drugs Containing a Spirocycle. Molecules 2023, 28, 4209.
Abstract
The use of spirocycles in drug discovery and medicinal chemistry has been booming in the last two decades. This has clearly translated in the landscape of approved drugs. Among two dozen clinically used medicines containing a spirocycle, 50% have been approved in the 21st century. The present review focuses on the notable synthetic routes to such drugs invented in industry and academia and is intended to serve as a useful reference source of synthetic as well as general drug information for researchers engaging in the design of new spirocyclic scaffolds for medicinal use or embarking upon analog syntheses inspired by the existing approved drugs.
Chemistry and Materials Science, Medicinal Chemistry
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
